HCPLive

MAY 18, 2024

A diagnosis of chronic kidney disease was approximately 3-times more likely in Crohn's disease than in ulcerative colitis.

Kidney Disease 111

Kidney Disease 111

HCPLive

FEBRUARY 2, 2024

Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.

Kidney Disease 105

Kidney Disease Obesity Hypertension 105

Journal of Clinical Investigation - Cardiology

OCTOBER 1, 2024

of cases, a qualifying potentially disease-causing rare variant in an established gene was found.

Kidney Disease 119

Kidney Disease Research 119

HCPLive

JANUARY 23, 2024

Findings from the retrospective cohort study suggest an increased prevalence of advanced kidney disease among individuals with Crohn disease and ulcerative colitis.

Kidney Disease 105

Kidney Disease 105

HCPLive

MAY 17, 2024

Check out this quiz on the NKF's KDOQI recommendations on nutrition in chronic kidney disease, with a focus on their guidance for protein and energy intake!

Kidney Disease 104

Kidney Disease 104

HCPLive

APRIL 17, 2024

The consensus calls for the recognition of kidney disease as a major non-communicable disease driver of premature mortality by the World Health Organization.

Kidney Disease 98

Kidney Disease 98

Journal of Clinical Investigation - Cardiology

MARCH 1, 2024

Two coding variants of apolipoprotein L1 (APOL1), called G1 and G2, explain much of the excess risk of kidney disease in African Americans. While various cytotoxic phenotypes have been reported in experimental models, the proximal mechanism by which G1 and G2 cause kidney disease is poorly understood.

Kidney Disease 102

Kidney Disease 102

HCPLive

DECEMBER 14, 2023

Microbiota-based interventions may be a novel strategy to benefit the mitigation of chronic kidney disease advancement.

Kidney Disease 98

Kidney Disease 98

Med Page Today

JANUARY 4, 2024

(MedPage Today) -- SGLT2 inhibitors significantly lowered the risk of death, major adverse kidney events (MAKE), and major adverse cardiovascular events (MACE) in people with type 2 diabetes and acute kidney disease, according to a cohort study.

Kidney Disease 92

Kidney Disease Diabetes 92

HCPLive

OCTOBER 25, 2024

After discontinuing therapy, treated participants still had an overall 13% reduction in the risk of kidney disease progression or cardiovascular death.

Kidney Disease 52

Kidney Disease 52

American Heart News - Heart News

MARCH 21, 2024

Research Highlights: A study of nearly 4 million young adults under age 40 in South Korea found that those who had ideal cardiovascular health were nearly two-thirds less likely to develop heart disease, stroke and/or kidney disease during a 12-year.

Kidney Disease 105

Kidney Disease Heart Disease Stroke Strokes 105

HCPLive

JANUARY 4, 2024

Compared to nonusers, patients with type 2 diabetes and acute kidney disease administered SGLT-2is had a significantly lower risk of mortality, major adverse kidney events, and major adverse cardiovascular events.

Kidney Disease 104

Kidney Disease Diabetes 104

Journal of Clinical Investigation - Cardiology

FEBRUARY 15, 2024

Ten percent of the population worldwide suffers from chronic kidney disease (CKD), but the mechanisms driving CKD pathology are incompletely understood. Identify acyl-CoA synthetase short-chain family 2 (ACSS2) as a disease risk gene and demonstrate a role for ACSS2 in de novo lipogenesis (DNL).

Kidney Disease 67

Kidney Disease Pharmacology 67

Journal of Clinical Investigation - Cardiology

FEBRUARY 15, 2024

Worldwide, over 800 million people are affected by kidney disease, yet its pathogenesis remains elusive, hindering the development of novel therapeutics. Lipid accumulation and the expression of genes related to DNL were elevated in the kidneys of patients with fibrosis.

Kidney Disease 81

Kidney Disease Pharmacology Ablation 81

The New England Journal of Medicine

OCTOBER 24, 2024

Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In this post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation.

Kidney Disease 40

Kidney Disease 40

HeartRhythm

NOVEMBER 28, 2024

Patients with chronic kidney disease (CKD) on renal replacement therapy (RRT) are at high risk for cardiovascular implantable electronic device (CIED) infections. Although device extraction is standard management, it is often avoided in these patients due to high procedural risks.

Kidney Disease 40

Kidney Disease Outcomes 40

Medical Xpress - Cardiology

DECEMBER 19, 2023

Heart failure is causally associated with chronic kidney disease (CKD), according to a study published online Dec. 11 in PLOS ONE.

Kidney Disease 70

Kidney Disease Heart Failure 70

Cardiovascular Diabetology

OCTOBER 8, 2024

Most existing risk equations for predicting/stratifying individual diabetic kidney disease (DKD) risks were developed using relatively dated data from selective and homogeneous trial populations comprising pre.

Kidney Disease 52

Kidney Disease Diabetes Research 52

Journal of Clinical Investigation - Cardiology

SEPTEMBER 3, 2024

The development of AAV2-GEC and its successful application in the treatment of antibody-mediated kidney disease represents a significant step forward and opens up promising avenues for kidney medicine. Taken together, this study showcases the potential of AAV as a gene delivery platform for challenging cell types.

Kidney Disease 81

Kidney Disease 81

HCPLive

NOVEMBER 13, 2024

People with diabetes, kidney stones, damaged joints, high uric acids, and daily use of NSAID were more likely to develop CKD than others.

Kidney Disease 105

Kidney Disease Diabetes 105

HCPLive

OCTOBER 26, 2024

The dapagliflozin group had an average eGFR rate of -2.24 mL/min/1.73 m2 compared to -3.67 mL/min/1.73 m2 in the control group after about 1.5 years of follow-up.

Kidney Disease 111

Kidney Disease 111

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundInhibition of prostaglandin synthesis by nonsteroidal anti‐inflammatory drugs is associated with cardiovascular mortality and kidney disease. Future studies should address whether these associations are causal and can be targeted to improve cardiovascular and kidney outcomes.

Kidney Disease 73

Kidney Disease Risk Factors Outcomes Diabetes 73

HCPLive

OCTOBER 28, 2024

Abdellatif discussed the importance of screening for osteopenia in patients with severe kidney disease.

Kidney Disease 52

Kidney Disease 52

Cardiovascular Diabetology

OCTOBER 23, 2024

A Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) formula not including a Black race coefficient has been recently developed and is now recommended in the US. The new (2021) equation was shown to.

Kidney Disease 52

Kidney Disease Diabetes Research 52

HeartRhythm

SEPTEMBER 11, 2024

End-stage kidney disease (ESKD) patients are prone to bloodstream infections which may result in a higher risk of cardiac implantable electronic device (CIED) infections.

Kidney Disease 40

Kidney Disease Outcomes 40

Hypertension Journal

DECEMBER 7, 2023

ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.

Kidney Disease 45

Kidney Disease Hypertension Pulmonary Atherosclerosis 45

Cardiovascular Diabetology

APRIL 9, 2024

Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.

Kidney Disease 64

Kidney Disease Hypertension Public Health Diabetes 64

Cardiovascular Diabetology

JUNE 14, 2024

Diabetic kidney disease is an established risk factor for heart failure. However, the impact of incident heart failure on the subsequent risk of renal failure has not been systematically assessed in diabetic p.

Kidney Disease 52

Kidney Disease Heart Failure Diabetes Risk Factors 52

HeartRhythm

NOVEMBER 5, 2024

Chronic kidney disease (CKD) and kidney failure with replacement therapy (KFRT) are prevalent in patients with atrial fibrillation (AF).

Kidney Disease 40

Kidney Disease Atrial Fibrillation Outcomes 40

Medical Xpress - Cardiology

DECEMBER 13, 2023

Renal dysfunction, especially chronic kidney disease, is the biggest risk factor of mortality among thrombolysed stroke patients, according to a retrospective cohort observational study published in Medicine.

Kidney Disease 40

Kidney Disease Thrombolysis Stroke Strokes 40

HCPLive

JULY 25, 2024

The sNDA for furosemide seeks to expand the indication to include the treatment of edema due to fluid overload in patients with CKD, with a PDUFA date of March 6, 2025.

Kidney Disease 109

Kidney Disease 109

Circulation

NOVEMBER 11, 2024

Background:There have been several studies postulating the association between Mitral valve stenosis (MS) and Chronic Kidney Disease (CKD). Circulation, Volume 150, Issue Suppl_1 , Page A4145373-A4145373, November 12, 2024.

Kidney Disease 40

Kidney Disease Bicuspid/Mitral Stenosis Document 40

HCPLive

JULY 23, 2024

Spigler provides insight into the development of new patient-focused guidelines for managing hyperkalemia in CKD and the importance of providing patients with such resources.

Kidney Disease 111

Kidney Disease Education 111

American College of Cardiology

JANUARY 11, 2024

The goal of the ASi in CKD trial was to determine the effect on albuminuria of BI 690517, an investigational aldosterone synthase inhibitor, alone and in combination with empagliflozin compared with placebo in patients with chronic kidney disease (CKD).

Kidney Disease 49

Kidney Disease Article 49

Coronary Artery Disease Journal

JUNE 18, 2024

Background Advanced chronic kidney disease (ACKD) is common in patients undergoing percutaneous coronary intervention (PCI) and is associated with adverse outcomes. These patients are often excluded from revascularization studies. The goal of this study was to evaluate the impact of ACKD in patients undergoing PCI.

Kidney Disease 40

Kidney Disease Inpatient Outcomes Research 40

Cardiovascular Diabetology

JANUARY 2, 2024

The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance and previous studies have confirmed the association of TyG index with incident chronic kidney disease (CKD). However, t.

Kidney Disease 59

Kidney Disease Diabetes Research 59

HCPLive

OCTOBER 25, 2024

New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.

Kidney Disease 64

Kidney Disease Diabetes Research 64